{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:34:16Z","timestamp":1762540456321,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.urology.2010.03.070","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T04:36:31Z","timestamp":1277267791000},"page":"513.e7-513.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Expression of Ki-67 and COX-2 in Patients With Upper Urinary Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"76","author":[{"given":"Hwang Gyun","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungbum","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Kyung","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ho","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Hoe","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunsik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2010.03.070_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.03.070_bib2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","article-title":"Behavior of urothelial carcinoma with respect to anatomical location","volume":"177","author":"Catto","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.03.070_bib3","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1136\/jmg.2003.017871","article-title":"Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma","volume":"41","author":"Roupret","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.urology.2010.03.070_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<299::AID-SSU3>3.0.CO;2-8","article-title":"Bladder cancer: natural history, tumor markers, and early detection strategies","volume":"13","author":"Foresman","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.urology.2010.03.070_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2008.07659.x","article-title":"Molecular and histological markers in urothelial carcinomas of the upper urinary tract","volume":"102","author":"Eltz","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.03.070_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","article-title":"Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections","volume":"168","author":"Cattoretti","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.urology.2010.03.070_bib7","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1158\/1078-0432.CCR-1052-03","article-title":"Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in Radiation Therapy Oncology Group protocol 86-10","volume":"10","author":"Li","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2010.03.070_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jso.20309","article-title":"Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma","volume":"92","author":"Morinaga","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.urology.2010.03.070_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0302-2838(01)00038-0","article-title":"p53 and Ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma","volume":"41","author":"Rodriguez-Alonso","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.03.070_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.urology.2007.09.061","article-title":"Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo","volume":"71","author":"Okamoto","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.03.070_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.ju.0000080401.85145.ee","article-title":"Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder","volume":"170","author":"Shariat","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.03.070_bib12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2004.05.174","article-title":"Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma","volume":"22","author":"Chatterjee","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2010.03.070_bib13","first-page":"829","article-title":"p53 and RB expression predict progression in T1 bladder cancer","volume":"4","author":"Grossman","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2010.03.070_bib14","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1158\/1078-0432.CCR-06-1472","article-title":"Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease","volume":"12","author":"Margulis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2010.03.070_bib15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.onc.1202452","article-title":"Level of retinoblastoma protein expression correlates with p16 (MTS-1\/INK4A\/CDKN2) status in bladder cancer","volume":"18","author":"Benedict","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2010.03.070_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02893426","article-title":"Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma","volume":"12","author":"Koksal","year":"2006","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.urology.2010.03.070_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1442-2042.2005.01159.x","article-title":"The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter","volume":"12","author":"Kamijima","year":"2005","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2010.03.070_bib18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G","article-title":"Tumor grade and stage as prognostic variables in upper tract urothelial tumors","volume":"62","author":"Huben","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2010.03.070_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0344-0338(97)80013-1","article-title":"Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy","volume":"193","author":"Suwa","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.urology.2010.03.070_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.03.070_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.2000.00726.x","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.03.070_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9440(10)64513-0","article-title":"Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas","volume":"157","author":"Komhoff","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urology.2010.03.070_bib23","first-page":"5647","article-title":"Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder","volume":"59","author":"Mohammed","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2010.03.070_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)64033-3","article-title":"Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder","volume":"158","author":"Ristimaki","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urology.2010.03.070_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W","article-title":"Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder","volume":"92","author":"Shirahama","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2010.03.070_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.ju.0000148272.77539.2d","article-title":"Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract","volume":"173","author":"Miyata","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.03.070_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1464-410X.2003.03057.x","article-title":"Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract","volume":"91","author":"Oku","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.03.070_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7","article-title":"E-cadherin expression in upper-urinary-tract carcinoma","volume":"74","author":"Nakanishi","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2010.03.070_bib29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjc.6601954","article-title":"Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb","volume":"91","author":"Hitchings","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2010.03.070_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/ejso.2002.1371","article-title":"Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder","volume":"29","author":"Santos","year":"2003","journal-title":"Eur J Surg Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510004899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510004899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:55:51Z","timestamp":1758765351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429510004899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0090429510004899"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2010.03.070","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Ki-67 and COX-2 in Patients With Upper Urinary Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2010.03.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}